Physician profile
Thomas E Hong
NPI 1235121294
$57,777.46
in general payments reported to CMS, 2019-2025
32 companies · $2,850 in 2025
The $2,850 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $12K · 2021: $7,443 · 2022: $11K · 2023: $6,643 · 2024: $6,172 · 2025: $2,850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $3,650 · Travel and Lodging: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,854.43 |
| Consulting Fee | $3,650.00 |
| Travel and Lodging | $160.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $39,176.27 | 2019-2025 | Allure, Accent, Gallant |
| Angiodynamics, INC. | $6,883.33 | 2021-2022 | |
| Biosense Webster, INC. | $6,496.68 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Boston Scientific Corporation | $1,556.62 | 2019-2025 | Wavewriter Alpha Prime 16, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Biotronik INC. | $826.15 | 2019-2021 | |
| Medtronic, INC. | $603.62 | 2021-2025 | Affera Mapping System, Hawkone, Azure Xt Dr Mri Surescan |
| Elutia, INC. | $289.33 | 2019-2025 | Ecm Patch,Pouch |
| Pfizer INC. | $260.19 | 2019-2024 | |
| Medtronic Vascular, INC. | $187.07 | 2019-2020 | |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Cardiva Medical, INC. | $155.67 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| E.R. Squibb & Sons, L.L.C. | $138.98 | 2020-2024 | Eliquis, Camzyos |
| Acutus Medical, INC. | $134.65 | 2019 | |
| Janssen Pharmaceuticals, INC | $117.47 | 2020-2022 | |
| Tactile Systems Technology INC | $102.93 | 2024 | Flexitouch Plus, Entre Plus |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $83.00 | 2019 | |
| Stryker Corporation | $72.68 | 2019-2020 | |
| G Medical Diagnostic Services, INC. | $63.25 | 2019 | |
| Sanofi-Aventis U.S. LLC | $63.21 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $60.58 | 2021-2022 | |
| Biotronik Nro, INC. | $56.86 | 2025 | Prospera |
| Kestra Medical Technology Services, INC. | $44.85 | 2025 | Assure Wcd |
| Becton, Dickinson and Company | $43.65 | 2025 | |
| Bridgebio Pharma, INC. | $29.98 | 2025 | Attruby |
| Mml US, INC. | $26.65 | 2025 | Reactiv8 |
| Altathera Pharmaceuticals LLC | $22.79 | 2022 | |
| Alnylam Pharmaceuticals INC. | $20.92 | 2024 | Onpattro |
| Atricure, INC. | $18.61 | 2019 | |
| Irhythm Technologies, INC. | $16.63 | 2024 | Zio Xt Patch |
| Avinger INC. | $15.92 | 2020 | |
| Ge Healthcare | $14.53 | 2023 | |
| Heartflow, INC. | $13.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.